BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 8607504)

  • 1. Maldigestion after total gastrectomy is associated with pancreatic insufficiency.
    Friess H; Böhm J; Müller MW; Glasbrenner B; Riepl RL; Malfertheiner P; Büchler MW
    Am J Gastroenterol; 1996 Feb; 91(2):341-7. PubMed ID: 8607504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total pancreatic insufficiency in pigs: a model to study intestinal enzymes and plasma levels of digestive hormones after pancreatic supplementation by a whole pancreas preparation.
    Abello J; Pascaud X; Simoes-Nunes C; Cuber JC; Junien JL; Rozé C
    Pancreas; 1989; 4(5):556-64. PubMed ID: 2478998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct measurement of pancreatic enzymes after stimulation with secretin versus secretin plus cholecystokinin.
    Del Rosario MA; Fitzgerald JF; Gupta SK; Croffie JM
    J Pediatr Gastroenterol Nutr; 2000 Jul; 31(1):28-32. PubMed ID: 10896067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exocrine pancreatic function in critically ill patients: septic shock versus non-septic patients.
    Tribl B; Madl C; Mazal PR; Schneider B; Spitzauer S; Vogelsang H; Gangl A
    Crit Care Med; 2000 May; 28(5):1393-8. PubMed ID: 10834684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma CCK levels in patients with pancreatic insufficiency.
    Bozkurt T; Adler G; Koop I; Koop H; Türmer W; Arnold R
    Dig Dis Sci; 1988 Mar; 33(3):276-81. PubMed ID: 3342719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of accuracy of plasma alpha-amino nitrogen profiles as an indicator of exocrine pancreatic function both after continuous and bolus stimulation of the pancreas with secretin and cholecystokinin-pancreozymin.
    Lembcke B; Konle O; Duan LP; Caspary WF
    Z Gastroenterol; 1994 Dec; 32(12):679-83. PubMed ID: 7871858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of high-dose pancreatic enzyme treatment on pancreatic function in healthy volunteers.
    Friess H; Kleeff J; Malfertheiner P; Müller MW; Homuth K; Büchler MW
    Int J Pancreatol; 1998 Apr; 23(2):115-23. PubMed ID: 9629509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maximal effective dose of cerulein in the secretin-cerulein test.
    Gullo L
    Digestion; 1988; 39(4):225-9. PubMed ID: 3065099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum pancreatic polypeptide estimations following hormonal stimulation for the diagnosis of exocrine pancreatic insufficiency.
    Cichy W; Lankisch PG; Arnold R; Creutzfeldt W
    Digestion; 1984; 30(4):218-23. PubMed ID: 6510573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Presence of hormonal polypeptides in the pure pancreatic secretion in man under stimulation by cerulein and secretin].
    Escourrou J; Pradayrol L; Chayvialle JA; Fagot-Revurat P; Pudebat M; Ribet A
    Gastroenterol Clin Biol; 1985 Nov; 9(11):782-6. PubMed ID: 2867946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of pancreatic secretion under long-term octreotide treatment in humans.
    Friess H; Bordihn K; Ebert M; Malfertheiner P; Kemmer T; Dennler HJ; Büchler MW
    Digestion; 1994; 55 Suppl 1():10-5. PubMed ID: 8132133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct measurement of pancreatic enzymes: a comparison of secretagogues.
    Pfefferkorn MD; Fitzgerald JF; Croffie JM; Gupta SK; Caffrey HM
    Dig Dis Sci; 2002 Oct; 47(10):2211-6. PubMed ID: 12395893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exocrine pancreatic insufficiency and idiopathic haemochromatosis.
    Jansen PL; Thien T; Lamers CB; Yap SH; Reekers P; Strijk S
    Postgrad Med J; 1984 Oct; 60(708):675-8. PubMed ID: 6494088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin, glucagon and gastrin secretion after cholecystokinin-pancreozymin and secretin stimulation in children with pancreatic insufficiency].
    Socha J; Bogoniowska Z; Barra E; Leśniewska A
    Pol Tyg Lek; 1984 May; 39(22):737-41. PubMed ID: 6387649
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic markers of protein maldigestion after a
    Mary F; Moesseler A; Khodorova N; Foucault-Simonin A; Benamouzig R; Tomé D; Gregory PC; Gaudichon C
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G223-G230. PubMed ID: 29074486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin influences pancreatic trophism following total gastrectomy in rats.
    Büchler M; Malfertheiner P; Friess H; Nustede R; Feurle GE; Beger HG
    Int J Pancreatol; 1989 Apr; 4(3):261-71. PubMed ID: 2668436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary isoamylase in duodenal aspirates.
    Lankisch PG; Otto J
    Dig Dis Sci; 1986 Dec; 31(12):1299-302. PubMed ID: 3803131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of fecal elastase-1 determination with the secretin-cholecystokinin test in patients with cystic fibrosis.
    Walkowiak J; Cichy WK; Herzig KH
    Scand J Gastroenterol; 1999 Feb; 34(2):202-7. PubMed ID: 10192202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretin-induced plasma bicarbonate decrease as a simple indicator of exocrine pancreatic function.
    Wettstein M; Häussinger D
    Pancreas; 1996 Aug; 13(2):193-7. PubMed ID: 8829188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cholecystokinin, secretin, and pancreatic polypeptide on secretion of gastric inhibitory polypeptide, insulin, and glucagon.
    Williams RH; Champagne J
    Life Sci; 1979 Sep; 25(11):947-56. PubMed ID: 513942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.